Author(s): Limce Thampi, Rani K Kuriakose, Aswani Balakrishnan, Muhsena P M, Sona Grace Nelson, T M Fathima Lulu, Veena Jayan

Email(s): limcesunil.02@gmail.com

DOI: 10.52711/2321-5844.2021.00017   

Address: Limce Thampi*, Rani K Kuriakose, Aswani Balakrishnan, Muhsena P M, Sona Grace Nelson, T M Fathima Lulu, Veena Jayan
Chemists College of Pharmaceutical Sciences and Research, Varikoli P.O, Puthencruz, Ernakulam, Kerala-682308, India.
*Corresponding Author

Published In:   Volume - 12,      Issue - 2,     Year - 2021


ABSTRACT:
Onychomycosis (Tinea unguium) is said to be the most common cosmetological nail fungal infection. Dermatophyte is a type of fungus that causes this condition. Discoloration and thickening of the nail are found to be the common symptoms of all nail diseases. In this scenario, Onychomycosis is considered as one of the cosmetic problems that leads to cellulitis in adults and diabetic patients. Anatomical structure of the nail and disease manifestations made nail disorders as a difficult endeavor. Onychomycosis is chronic and difficult to eradicate. Many oral antifungal agents are available for the treatment of nail infections. The oral and parenteral administration of antifungal agents can elevate the serum hepatic enzyme levels and causes typical hepatocellular injury within a few weeks of therapy. The goal of this review is to study the role of transungal delivery systems (nail patches) as a promising tool for onychomycosis to encounter the clinical conditions of the patient. Longer therapies and technical treatment methods may frustrate the patients. This novel antifungal therapy helps to avoid the surgical removal of nail for onychomycosis patients. Eradication of issues with Onychomycosis can be achieved by an excellent delivery system with deeper drug release and drug retention in the nail cuticle. Patients who are suffered from onychomycosis are facing embarrassment and disfigurement in the society. So, this newer treatment solution can improve the quality of life of patients.1-3


Cite this article:
Limce Thampi, Rani K Kuriakose, Aswani Balakrishnan, Muhsena P M, Sona Grace Nelson, T M Fathima Lulu, Veena Jayan. Cosmetological competence of nail patches in combating onychomycosis-An approach to improve the quality of life. Research Journal of Topical and Cosmetic Sciences. 2021; 12(2):125-1. doi: 10.52711/2321-5844.2021.00017

Cite(Electronic):
Limce Thampi, Rani K Kuriakose, Aswani Balakrishnan, Muhsena P M, Sona Grace Nelson, T M Fathima Lulu, Veena Jayan. Cosmetological competence of nail patches in combating onychomycosis-An approach to improve the quality of life. Research Journal of Topical and Cosmetic Sciences. 2021; 12(2):125-1. doi: 10.52711/2321-5844.2021.00017   Available on: https://rjtcsonline.com/AbstractView.aspx?PID=2021-12-2-8


REFERENCES:
1.    Muralidhar P, Bhargav E, Reddy R. Transungual drug delivery: an over view. Int J Pharma Res Heal Sci. 2017;5:1522-8.doi: 10.21276/ijprhs.2017.01.01
2.    De Doncker P, Gupta AK, Marynissen G, Stoffels P, Heremans A. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview. Journal of the American Academy of Dermatology. 1997 Dec 1;37(6):969-74.doi:10.1016/S0190-9622(97)70074-4
3.    GaddimeSonali B, Nagoba SN, Pattewar Shraddha G, Wadulkar RD, Thonte SS. Formulation and Evaluation of Medicated Nail Patches for the Treatment of Onychomycosis.International Journal of Pharmaceutical Science Invention.2018 April;7(4):52-58.
4.    Rai S, Kamath BV, Subrahmanyam VM. Strategies for treatment of Onychomycosis. Research Journal of Pharmacy and Technology. 2018;11(11):5135-8. doi:10.5958/0974-360X.2018.00937.X
5.    Javeth A, Mathur RG, Babu M. A correlational survey to assess the level of stress, coping strategies, and quality of life of female cancer patients related to chemotherapy induced alopecia in Amala Cancer Hospital, Thrissur, Kerala. Asian Journal of Nursing Education and Research. 2017;7(1):1-6.doi: 10.5958/2349-2996.2017.00001.5
6.    Queller JN, Bhatia N. The dermatologist’s approach to onychomycosis. Journal of Fungi. 2015 Sep;1(2):173-84.doi: 10.3390/jof1020173
7.    Aggarwal R, Targhotra M, Sahoo PK, Chauhan MK. Onychomycosis: Novel strategies for treatment. Journal of Drug Delivery Science and Technology. 2020 Jun 1;57:101774.doi: 10.1016/j.jddst.2020.101774
8.    McAuley WJ, Jones SA, Traynor MJ, Guesné S, Murdan S, Brown MB. An investigation of how fungal infection influences drug penetration through onychomycosis patient’s nail plates. European Journal of Pharmaceutics and Biopharmaceutics. 2016 May 1;102:178-84.doi: 10.1016/j.ejpb.2016.03.008
9.    Sánchez Regaña M, Márquez Balbás G, Umbert Millet P. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. Journal of the European Academy of Dermatology and Venereology. 2008 Aug;22(8):963-9.doi: 10.1111/j.1468-3083.2008.02679.
10.    Pal P, Thakur RS, Ray S, Mazumder B. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis. Drug development and industrial pharmacy. 2015 Jul 3;41(7):1095-9.doi: 10.3109/03639045.2014.931966
11.    Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clinical Microbiology Reviews. 1998 Jul 1;11(3):415-29.doi: 10.1128/CMR.11.3.415
12.    Varghese JJ. Effectiveness of Planned health teaching on awareness of ill effects of tobacco consumption and its impact on quality of life among the adults of selected slum area, Pune City. International Journal of Nursing Education and Research. 2015;3(3):275-80.doi:10.5958/2454-2660.2015.00007.1
13.    Dwaish MS. Anti-dermatophytes activity of some algal extracts isolated From Baghdad City-Iraq. Research Journal of Pharmacy and Technology. 2018;11(12):5449-54.doi: 10.5958/0974-360X.2018.00993.9
14.    Westerberg DP, Voyack MJ. Onychomycosis: current trends in diagnosis and treatment. American Family Physician. 2013 Dec 1;88(11):762-70.
15.    Arenas R, Fernández G, Dornínguez L. Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. International Journal of Dermatology. 1991 Aug;30(8):586-9.doi: 10.1111/j.1365-4362.1991.tb02648
16.    Tupaki-Sreepurna A, Jishnu BT, Thanneru V, Sharma S, Gopi A, Sundaram M, Jyoti Kindo A. An assessment of in vitro antifungal activities of efinaconazole and itraconazole against common non-dermatophyte fungi causing onychomycosis. Journal of Fungi. 2017 Jun;3(2):20.doi: 10.3390/jof3020020
17.    Piérard G. Onychomycosis and other superficial fungal infections of the foot in the elderly: a pan-European survey. Dermatology. 2001;202(3):220-4.doi: 10.1159/000051640
18.    Matsuda Y, Sugiura K, Hashimoto T, Ueda A, Konno Y, Tatsumi Y. Efficacy coefficients determined using nail permeability and antifungal activity in keratin-containing media are useful for predicting clinical efficacies of topical drugs for onychomycosis. PLoS One. 2016 Jul 21;11(7):e0159661.doi: 10.1371/journal.pone.0159661
19.    Finch JJ, Warshaw EM. Toenail onychomycosis: current and future treatment options. Dermatologic Therapy. 2007 Jan;20(1):31-46. doi: 10.1111/j.1529-8019.2007.00109
20.    Silva-Neves V, Hugo V, Alves P, Amado JC, Pais-Vieira C, Sousa F, Cerqueira F, Pinto E, Pais-Vieira M. Quality of life and therapeutic regimen management in onychomycosis patients and in vitro study of antiseptic solutions. Scientific Reports. 2021 Jun 17;11(1):1-0. doi:10.1038/s41598-021-92111-4
21.    Matthieu L, De Doncker P, Cauwenbergh G, Woestenborghs R, Van de Velde V, Janssen PA, Dockx P. Itraconazole penetrates the nail via the nail matrix and the nail bed—an investigation in onychomycosis. Clinical and Experimental Dermatology. 1991 Sep;16(5):374-6.doi: 10.1111/j.1365-2230.1991.tb00405
22.    Akhtar N, Sharma H, Pathak K. Onychomycosis: potential of nail lacquers in transungual delivery of antifungals. Scientifica. 2016 Mar 30;2016.doi: 10.1155/2016/1387936
23.    Kushwaha A, Jacob M, Shiva Kumar HN, Hiremath S, Aradhya S, Repka MA, Murthy SN. Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug development and industrial pharmacy. 2015 Jul 3;41(7):1089-94.doi: 10.3109/03639045.2014.927481
24.    Srinidhi KR, Subrahmanyam VM, Alex AT, Mathew AJ, Kamath BV. Role of Nano-formulation in the treatment of Onychomycosis. Research Journal of Pharmacy and Technology. 2020;13(1):453-5.doi: 10.5958/0974-360X.2020.00088.8
25.    Rahman A, Aqil M, Ahad A, Imam SS, Qadir A, Ali A. Application of central composite design for the optimization of itraconazole loaded nail lacquer formulation. 3 Biotech. 2021 Jul;11(7):1-6.doi:10.1007/s13205-021-02862-0
26.    Willemsen M, De Doncker P, Willems J, Woestenborghs R, Van de Velde V, Heykants J, Van Cutsem J, Cauwenbergh G, Roseeuw D. Posttreatmentitraconazole levels in the nail: new implications for treatment in onychomycosis. Journal of the American Academy of Dermatology. 1992 May 1;26(5):731-5.doi: 10.1016/0190-9622(92)70102-L
27.    Miron D, Cornelio R, Troleis J, Mariath J, Zimmer AR, Mayorga P, Schapoval EE. Influence of penetration enhancers and molecular weight in antifungals permeation through bovine hoof membranes and prediction of efficacy in human nails. European Journal of Pharmaceutical Sciences. 2014 Jan 23;51:20-5.doi: 10.1016/j.ejps.2013.08.032
28.    Pandhi D, Verma P. Nail avulsion: indications and methods (surgical nail avulsion). Indian Journal of Dermatology, Venereology and Leprology. 2012 May 1;78(3):299.doi: 10.4103/0378-6323.95444
29.    Dhamoon RK, Popli H, Gupta M. Novel drug delivery strategies for the treatment of onychomycosis. Pharmaceutical Nanotechnology. 2019 Feb 1;7(1):24-38.doi: 10.2174/2211738507666190228104031
30.    Angelo T, Borgheti-Cardoso LN, Gelfuso GM, Taveira SF, Gratieri T. Chemical and physical strategies in onychomycosis topical treatment: A review. Medical Mycology. 2017 Jul 1;55(5):461-75.doi: 10.1093/mmy/myw084
31.    Trey SM, Wicks DA, Mididoddi PK, Repka MA. Delivery of itraconazole from extruded HPC films. Drug Development and Industrial Pharmacy. 2007 Jan 1;33(7):727-35.doi: 10.1080/03639040701199225
32.    Amutha JJ. Effectiveness of selected nursing interventions on Fatigue and Quality of life among Chronic Renal Failure patients undergoing Hemodialysis in a selected hospital at Madurai. International Journal of Advances in Nursing Management. 2021 Jul 1;9(3):269-74.doi: 10.52711/2454-2652.2021.00061
33.    Drake LA, Patrick DL, Fleckman P, André J, Baran R, Haneke E, Sapède C, Tosti A. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. Journal of the American Academy of Dermatology. 1999 Aug 1;41(2):189-96.doi: 10.1016/S0190-9622(99)70047-2
34.    Szepietowski JC, Reich A, Pacan P, Garlowska E, Baran E, Polish Onychomycosis Study Group. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis‐specific questionnaire. Journal of the European Academy of Dermatology and Venereology. 2007 Apr;21(4):491-6.doi: 10.1111/j.1468-3083.2006.02004.
35.    Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. Journal of Dermatological Treatment. 2003 Jan 1;14(2):95-8.doi: 10.1080/09546630310012109
36.    Saunte DM, Holgersen JB, Hædersdal M, Strauss G, Bitsch M, Svendsen OL, Arendrup MC, Svejgaard EL. Prevalence of toe nail onychomycosis in diabetic patients. Acta Dermato-Venereologica. 2006 Sep 1;86(5):425-8.doi:10.2340/00015555-0113
37.    Larsen GK, Haedersdal M, Svejgaard EL. The prevalence of onychomycosis in patients with psoriasis and other skin diseases. Acta Dermato-Venereologica. 2003 Jan 1;83(3):206-9.doi:  10.1080/00015550310007229
38.    Levy LA. Epidemiology of onychomycosis in special-risk populations. Journal of the American Podiatric Medical Association. 1997 Dec;87(12):546-50.doi: 10.7547/87507315-87-12-546
39.    Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, Sharpe C. Toenail onychomycosis: an important global disease burden. Journal of Clinical Pharmacy and Therapeutics. 2010 Oct;35(5):497-519./doi: 10.1111/j.1365-2710.2009.01107
40.    Zaias N. Onychomycosis. In The nail in health and disease. Miami Beach, Florida. 1980;1st ed:pp.91-96 .doi:10.1007/978-94-011-7846-4_8
41.    Seebacher C, Brasch J, Abeck D, Cornely O, Effendy I, Ginter-Hanselmayer G, Haake N, Hamm G, Hipler UC, Hof H, Korting HC. Onychomycosis. Mycoses. 2007 Jul;50(4):321-7. doi: 10.1111/j.1439-0507.2006.01351
42.    Scher RK. Onychomycosis: a significant medical disorder. Journal of the American Academy of Dermatology. 1996 Sep 1;35(3):S2-5.doi: 10.1016/S0190-9622(96)90061-4
43.    Baran R, Hay RJ, Garduno JI. Review of antifungal therapy and the severity index for assessing onychomycosis: part I. Journal of Dermatological Treatment. 2008 Jan 1;19(2):72-81.doi: 10.1080/09546630701243418
44.    Gupta MD AK, De Doncker PhD P, Scher MD RK, Haneke MD E, Daniel III MD RC, André MD J, Baran MD R. Itraconazole for the treatment of onychomycosis. International Journal of Dermatology. 1998 Apr;37(4):303-8.doi: 10.1046/j.1365-4362.1998.00360
45.    Vlahovic TC. Onychomycosis: evaluation, treatment options, managing recurrence, and patient outcomes. Clinics in Podiatric Medicine and Surgery. 2016 Jul 1;33(3):305-18. doi: 10.1016/j.cpm.2016.02.001
46.    Elewski BE. Mechanisms of action of systemic antifungal agents. Journal of the American Academy of Dermatology. 1993 May 1;28(5):S28-34.doi: 10.1016/S0190-9622(09)80305-8

Recomonded Articles:

Author(s): Beedha. Saraswathi, SK. Shabana, D. Ramya Sri, D. Anantha Lakshmi, M. Shivaji, T. Satyanarayana

DOI: 10.5958/2321-5844.2017.00006.1         Access: Open Access Read More

Author(s): S. B. Gondkar, Nikita S. Malekar , R.B.Saudagar

DOI:         Access: Open Access Read More

Author(s): Katta. Manogna, E. Nanda Krishna Reddy, T.N. Shilpa

DOI: 10.5958/2321-5844.2017.00008.5         Access: Open Access Read More

Author(s): Suman Shrivastava, Rakesh Tirkey, Adeep Kujur, Rajendra Jangde, Sanjay J. Daharwal

DOI: 10.5958/2321-5844.2017.00005.X         Access: Open Access Read More

Author(s): Deepak S. Kshirsagar, R. B. Saudagar

DOI: 10.5958/2321-5844.2016.00006.6         Access: Open Access Read More

Author(s): Dattatreya B Udgirkar, Hiremath Doddayya

DOI:         Access: Open Access Read More

Author(s): Manmohan S. Jangdey, Anshita Gupta , Abhishek K. Sah

DOI:         Access: Open Access Read More

Author(s): Nilesh V. Kadam, Vijay R. Mahajan

DOI:         Access: Open Access Read More

Author(s): D.B. Pandya, D.M. Shinkar, R.B. Saudagar

DOI: 10.5958/2321-5844.2015.00010.2         Access: Open Access Read More

Author(s): Shushank Sharma, Shikha Baghel Chauhan

DOI: 10.52711/2321-5844.2021.00003         Access: Closed Access Read More

Author(s): Lakshmi Usha Ayalasomayajula, M. Kusuma Kumari, Radha Rani Earle

DOI: 10.52711/2321-5844.2021.00002         Access: Closed Access Read More

Author(s): Preeti Mehra, Vishal Kapoor, Naveen Gupta, Dharmendra Singh Rajpoot, Neeraj Sharma

DOI: 10.52711/2321-5844.2021.00009         Access: Closed Access Read More

Author(s): Saloni Manglik, Jaya Singh

DOI: 10.52711/2321-5844.2021.00011         Access: Closed Access Read More

Author(s): Limce Thampi, Rani K Kuriakose, Aswani Balakrishnan, Muhsena P M, Sona Grace Nelson, T M Fathima Lulu, Veena Jayan

DOI: 10.52711/2321-5844.2021.00017         Access: Closed Access Read More

Author(s): Shushank Sharma

DOI: 10.52711/2321-5844.2021.00016         Access: Closed Access Read More

Research Journal of Topical and Cosmetic Sciences (RJTCS) is an international, peer-reviewed journal, correspondence in the fields of skin and cosmetic research....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2321-5844 


Recent Articles




Tags